Kerentech logo — Fundraising for Life Sciences companies in high-risk therape...

Kerentech

Fundraising for Life Sciences companies in high-risk therapeutic areas. Experience $5M-$60M

Founded 2004 Israel Israel 2 employees Biotechnology, Health Care

General Information

Company Name Kerentech
Founded Year 2004
Location Israel Israel +2
Employees 2
Industries Biotechnology, Health Care
Social

Get notified when Kerentech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kerentech

Kerentech is a company specializing in fundraising for Life Sciences companies operating in high-risk therapeutic areas, with a focus on experience ranging from $5M-$60M. The company's expertise lies in the search for investors for Life Sciences and Medtech companies, facilitating Outlicense, Joint Ventures, M&A, specific business development related to pharma, biotech, and medtech, as well as IP trade and negotiation. Based in Spain and Israel, Kerentech serves a global clientele, including the United States, United Kingdom, France, Israel, Spain, India, China, and Hong-Kong. Kerentech has minimal transaction requirements for Drug Development and Medtech, with experience spanning from start-ups and spin-offs to PIPE in Nasdaq quoted companies, phase III transactions. The company also specializes in fundraising for incubators, funds, and operations between funds focused on Life Sciences. With a team possessing more than 40 accumulated years of experience, Kerentech was founded in 2003. Overall, Kerentech presents an opportunity for investors to engage with a company that has a significant track record in fundraising and supporting innovative ventures within the Biotechnology and Health Care industries. For further information, interested parties can reach out to info (at) kerentech.com.

Taxonomy: Life Sciences Fundraising, Medtech Business Development, Pharma Investment, Biotech Startup Funding, Joint Venture Negotiation, Outlicensing Services, Mergers & Acquisitions, Medical Device IP Trading, Drug Development Financing, Proof of Concept Funding, Investor Search, Venture Capital Facilitation, Co-development Agreements, Patent Financing, Portfolio Co-investment

No funding data available for Kerentech yet.

Get notified when Kerentech raises funding

Kerentech Alternatives & Competitors

Kerentech vs
CvilleBioHub
CvilleBioHub United States

Fostering Innovation. Accelerating Life Sciences.

Grant
20 employees
Biotechnology
Kerentech vs
Seroba.
Seroba. Ireland

A leading European life sciences venture capital firm.

13 employees
Biotechnology, Financial Services
Kerentech vs
Go Develop
Go Develop United Kingdom

100% land and build joint venture funder

2 employees
Legal Tech, Platforms

FAQ About Kerentech

Fundraising for Life Sciences companies in high-risk therapeutic areas. Experience $5M-$60M
Kerentech was founded in 2004.
Kerentech is headquartered in Israel.
Kerentech operates in the following industries: Biotechnology, Health Care.
Kerentech has approximately 2 employees.
Top alternatives and competitors to Kerentech include CvilleBioHub, Seroba., Go Develop, BioPark Regensburg GmbH, American Life, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kerentech and CvilleBioHub are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kerentech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy